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ABSTRACT

Ng, Ka Ho. M.S., Purdue University, December 2016. Dopamine D1 Receptor
Activity in the Basolateral Amygdala is Important for Mediating Fear, Reward and
Safety Discrimination Learning. Major Professor: Susan Sangha.

Post traumatic stress disorder (PTSD) patients frequently show impairment in safety
learning (Jovanovic, Kazama, Bachevalier, & Davis, 2012). Since the amygdala is
known to be critical for emotional processing(Wassum & Izquierdo, 2015) and
dopamine signaling in the amygdala is important for mediating both fear and reward
learning, current experiments examined the role of dopamine signaling in the BLA in
mediating both safety learning and reward seeking. We manipulated dopamine D1
receptor activity with a D1 receptor agonist (SKF 38393) or D1 receptor antagonist
(SCH23390) either systemically or infused directly into the BLA 20 minutes prior to
training rats in a fear-safety-reward cue discrimination learning task (Sangha, Chadick,
& Janak, 2013). Systemic administration of either the D1 receptor agonist or antagonist
impaired fear and safety discrimination learning. The systemic administration of the
D1 receptor agonist, but not the antagonist, also impaired discriminative fear and
discriminative reward seeking. BLA infusion of the agonist, but not the antagonist,
replicated the impairment in fear and safety discrimination learning but not
discriminative reward seeking. This study demonstrates that D1 receptor activity in the
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BLA is not needed for fear learning, safety learning or discriminative reward seeking,
but an increase in dopamine D1 receptor activity within the BLA impairs fear
suppression in the presence of the safety signal.

1

INTRODUCTION

Current drug therapy for posttraumatic stress disorder (PTSD) lacks specificity,
and more targeted treatment is needed. The results of a 2016 meta-analysis study
indicate that SSRI and SNRI antidepressants are most commonly recommended for the
treatment of PTSD (Lee et al., 2016). The two most effective medications, Venlafaxine
and Nefazodone, lack sustained benefits and can trigger severe side effects,
respectively (Lee et al., 2016). A better understanding of the underlying neural circuit
would allow the development of more specific drugs to rescue dysregulations in fear
suppression. This approach may lead to the development of drugs with longer lasting
benefits upon treatment completion and with less side effects. Given that PTSD affects
approximately 8.7% of the general population within their lifetime(Kessler et al.,
2005), there is a critical need to map out the neural circuitry underlying emotional
regulation to stimulate development of more targeted drug treatments. PTSD patients
have an inability to discriminate between danger and safety (Jovanovic et al., 2009),
and they have impairments in fear extinction(Morriss, Christakou, & Van Reekum,
2015). Current literature has mostly focused on the reward and fear learning circuits
separately. Integrating the safety circuit with the fear and reward circuit is essential for
understanding how safety signals elicit approach behaviors and inhibit avoidance
behaviors. Without an understanding of the integrated fear-reward-safety circuitry, we
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will continue to have knowledge gaps with respect to fear dysregulation by safety
signals in PTSD patients.
Overview of Neural Circuitry of Emotion Learning (Figure 1)
The amygdala is critical for both fear and reward learning (Wassum &
Izquierdo, 2015). It receives input from the sensory insular cortex (SI)(Kong, Monje,
Hirsch, & Pollak, 2014), prefrontal cortex (PFC) (Vertes, 2004), hippocampus
(Ishikawa & Nakamura, 2006), and ventral tegmental area (VTA)(Abraham, Neve, &
Lattal, 2014). Inputs from those brain structures into the amygdala are critical in
mediating complex emotional learning. The SI receives sensory input from different
modalities and is important for safety expression (J. P. Christianson et al., 2008). The
infralimbic cortex (IL) of the PFC is important for fear extinction(Kong et al., 2014).
The hippocampus is important for fear extinction (Corcoran & Maren, 2001). The
dorsal hippocampus, in addition to being involved with fear learning (Rossato,
Bevilaqua, Izquierdo, Medina, & Cammarota, 2009), is also involved with reward
learning (Luo, Tahsili-Fahadan, Wise, Lupica, & Aston-Jones, 2011). Similar to the
amygdala, the VTA also responds to both valences. Dopamine neurons in the dorsal
portion of the VTA are responsive to rewards and dopamine neurons in the ventral
portion are responsive to aversive events (Abraham et al., 2014). All of these inputs
converge in the amygdala and will affect the outputs to the nucleus accumbens (NAc)
(Wassum & Izquierdo, 2015) and periaqueductal gray (PAG)(Herry & Johansen,
2014), among others, for behavioral expression. The NAc mediates both appetitive
and avoidance behaviors (Richard & Berridge, 2011) and the PAG is necessary for
conditioned freezing expression(Pape & Pare, 2010).
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General Overview of the Amygdala in Emotion Learning
The amygdala can be roughly divided into central amygdala (CeA) and
basolateral amygdala (BLA). This structure is important for detecting salient stimuli,
and eliciting approach or avoidance behaviors in response to either reinforcing or
aversive environmental signals (Janak & Tye, 2015; Weymar & Schwabe, 2016). The
CeA, which is divided into the lateral portion (CeL) and medial portion (CeM), is made
up of mostly GABAergic neurons(Janak & Tye, 2015). The CeA is necessary for fear
expression and conditioned orientating responses to the reward CS. It receives direct
input from the BLA as well as indirect BLA input via GABAergic intercalated cells
located between the BLA and CeA (Amano, Unal, & Paré, 2010; Janak & Tye, 2015).
In contrast, the BLA which includes the basal amygdala (BA), basomedial amygdala
(BM) and lateral amygdala (LA) is mostly made up of glutamatergic principal neurons
and inhibitory interneurons (Janak & Tye, 2015). Glutamatergic principle neurons
make up approximately 80 percent of the cells in the BLA, and they make connection
with each other through excitatory projections. They also relay inputs from the LA to
the BM. The remaining 20 percent are GABAergic interneurons (Pape & Pare, 2010).
The BLA is critical for fear expression (Sierra-Mercado, Padilla-Coreano, & Quirk,
2011) and avoidance expression (Bravo-Rivera, Roman-Ortiz, Brignoni-Perez, SotresBayon, & Quirk, 2014). There is evidence showing that fear memories are stored
within the BLA. Reactivation of fear memories followed by infusion of a protein
synthesis inhibitor, anisomycin, into the BLA disrupts memory in future tests. This
effect is observable for both newly formed and older memories (Nader, Schafe, & Le
Doux, 2000).
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The LA is an important sensory input area of the BLA for receiving both
conditioned stimulus (CS) and unconditioned stimulus (US) information. CS input
enters the LA through projections from the medial geniculate nucleus(MGn) and
auditory cortex (AC) (Tsvetkov, Carlezon, Benes, Kandel, & Bolshakov, 2002).
Optical stimulation of inputs from AC and MGn to the LA can effectively replace an
auditory CS during fear conditioning (Nabavi et al., 2014). There are at least two
sources of plasticity within this pathway during learning. It has been demonstrated that
the synaptic input from the AC to the LA shows long term potentiation(LTP) during
fear conditioning (Tsvetkov et al., 2002). Inducing long term depression (LTD) or
inducing LTP at the synaptic input to the LA following paired training can abolish or
reactivate conditioned suppression, respectively (Nabavi et al., 2014). There is
evidence showing that the learning induced LTP in the synapse from auditory cortex to
the LA is attributed to the increase in presynaptic neurotransmitter release probability,
but not quantal amplitude (Tsvetkov et al., 2002). Stress exposure can enhance this
LTP by increasing the number of postsynaptic NMDA receptors in LA principal
neurons leading to the overall facilitation in fear consolidation (Suvrathan et al., 2014).
This fear facilitation might contribute to the resistance in fear extinction observed in
individuals with anxiety disorders.
In addition to synaptic changes in the inputs to the LA, plasticity can also be
observed downstream within the LA. During fear conditioning, the LA shows an
increase in short latency activity to the auditory CS. This effect can be observed in as
little as five fear conditioning trials and the increase in LA activity persists even when
conditioning continues for 70 more trials. This further supports the idea that fear
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memories are established and stored within the LA (Maren, 2000). In addition, the LA
receives US input from the spinal/ trigeminal dorsal horn through the periaqueductal
gray(PAG) during fear conditioning (Herry & Johansen, 2014). The optical stimulation
of LA pyramidal neurons within the amygdala can effectively replace a footshock US
and cause animals to subsequently show conditioned freezing to an auditory CS that
was previously paired with the optical stimulation (Johansen et al., 2010). Taken
together, this pairing of CS and US leads to the strengthening of CS input to the LA
during fear conditioning, and it becomes easier for the CS to activate the LA without
the unconditioned stimulus (US) input to the LA (Janak & Tye, 2015). The finding that
LA activation can serve as an effective US, producing conditioned freezing responses,
supports the idea that CS activation of LA pyramidal neurons during conditioning is
critical for driving fear memory formation (Johansen et al., 2010).
In addition to fear learning, the amygdala plays a role in reward learning. It
encodes reward value and neurons in the amygdala respond to the visual presentation
of food only when it’s palatable (Wassum & Izquierdo, 2015). The neurons in the
BLA have been found to encode information for reward anticipation and reward
contingency (Hernádi, Grabenhorst, & Schultz, 2015; Sugase-Miyamoto & Richmond,
2005). BLA neurons also show increases in firing to the reward cue during paired
training (Tye & Janak, 2007), and encode changes in reward value by encoding both
positive and negative prediction error(Wassum & Izquierdo, 2015). With respect to
reward, there is a population of BLA neurons that are responsive to the cue only when
the animal is seeking reward, and a different population of BLA neurons that are
responsive to the reward cue regardless if the animal is seeking reward (Tye & Janak,
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2007). Projections from the BLA to the NAc shell (NAs) is necessary for reward
seeking extinction expression(Millan & McNally, 2011) .
Taken together, the BLA regulates both positive and negative emotions. This
idea was also supported by a recent publication from our lab looking at fear-rewardsafety discrimination learning in rats. We found that the BLA contains fear neurons
that show selective responses to the fear cue, safety neurons that show selective
responses to the safety cue, and safety + reward neurons that show selective responses
to the safety and reward cues (Sangha, Chadick, & Janak, 2013). In addition, the BLA
receives projections from the prelimbic cortex (PL) and the infralimbic cortex
(IL)(Vertes, 2004). Follow up local inactivation studies from our lab have shown that
the PL is necessary for fear expression and discriminative reward seeking, and the IL is
necessary for fear and safety discrimination (Sangha, Robinson, Greba, Davies, &
Howland, 2014). These findings suggest that inputs from upstream BLA structures may
contribute to the learning related changes observed in the BLA during fear, safety and
reward discrimination.
Dopamine Signaling
Midbrain dopamine neurons are predominantly located in the VTA, substantia
nigra pars compacta (SNc) and retrorubral field (RRF) (Lammel, Lim, & Malenka,
2014). They are responsive to reward cues and to the unexpected delivery of rewards
(Schultz, 2013). Past studies have identified dopamine neurons based on the presence
of Ih current and responsiveness to dopamine application. However, not all dopamine
neurons show these characteristics(Lammel et al., 2014). In addition, dopamine
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neurons can be GABAergic or glutamatergic and therefore can release GABA or
glutamate in addition to dopamine(Lammel et al., 2014).
A typical dopamine response can be divided into two components. The faster
stimulus detection component is important in directing attention and allowing a quicker
response to the potential reward. The magnitude of this component is dependent on the
intensity of the signal, similarity with other reward signals, presentation context, and
novelty of the cue (Schultz, 2016). The slower component encodes prediction error,
which reflects the difference between expected and obtained. An increase in firing can
be observed when an obtained reward is higher than expected, and decreased firing can
be observed when an obtained reward is lower than expected. No change is observed
when an obtained reward is fully expected (Schultz, 2013, 2016). This prediction error
serves as a teaching signal and provides feedback about changes in reward delivery to
drive learning. Mimicking a prediction error by activating dopaminergic neurons
during reward delivery leads to an enhancement in cue driven reward seeking
(Steinberg et al., 2013). In addition, midbrain dopaminergic neurons are responsive to
unpleasant stimuli. Since this increase in firing occurs at the end of an aversive
stimulus, this might be due to the reinforcing effect from removal of the aversive
stimulus (Schultz, 2013).
Dopamine Receptors
There are five subtypes of dopamine receptors: D1, D2, D3, D4 and D5.
Binding of dopamine to D1 or D5 receptors activates stimulatory G proteins and leads
to the stimulation of adenylate cyclase activity and production of cyclic adenosine
monophosphate (cAMP). In contrast, binding of dopamine to D2, D3 or D4 receptors
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activates inhibitory G proteins and decreases adenylate cyclase activity (Abraham et
al., 2014). Dopamine receptors can be found throughout the brain. Dopamine D1 and
D2 receptors are both expressed in the PFC, NAc, intercalated cells of the amygdala,
hippocampus, and striatum. D2 receptors are more selectively expressed in the CEA,
substantia nigra, and VTA, whereas D1 receptors are more selectively expressed in the
BLA (Weiner et al., 1991). Dopaminergic signaling within the BLA is important for
both fear and reward learning. Within the BLA, dopamine levels increase during fear
conditioning (de Oliveira et al., 2011) and D1 receptor activity within the BLA is
needed for the acquisition of fear extinction(Hikind & Maroun, 2008). Both D1 and
D2 receptor activity modulates risk decisions during a reward uncertainty task(Larkin,
Jenni, & Floresco, 2016).
Dopaminergic Circuits
The VTA is a critical upstream structure since it sends dopaminergic
projections to diverse brain regions regulating both reward and aversive learning. The
VTA has projections to both the prelimbic (PL) and infralimbic (IL) cortex through the
mesocortical pathway (Abraham et al., 2014). The PL and the IL in turn project to the
BLA (Vertes, 2004). Local inactivation studies have shown that the PL is necessary
for fear expression and discriminative reward seeking, and the IL is necessary for fear
and safety discrimination(Sangha, Robinson, et al., 2014). The VTA also has direct
projections to the BLA, CEA, hippocampus and the NAc through the mesolimbic
pathway (Abraham et al., 2014). This projection from the VTA to the BLA is important
for fear learning. Normally, dopamine levels in the BLA increase during fear
conditioning (de Oliveira et al., 2011). An increase in D2 receptor activity in the VTA
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has been shown to block both conditioned freezing and the learning related increases in
dopamine levels within the BLA (de Oliveira et al., 2011). The BLA also receives a
direct projection from the ventral hippocampus (Ishikawa & Nakamura, 2006), as well
as an indirect projection from the ventral hippocampus (Verwer, Meijer, Van Uum, &
Witter, 1997) via the PFC (Brinley-Reed, Mascagni, & McDonald, 1995). Dopamine
receptor activity in the NAc has also been implicated in regulating opposing emotions.
D1 receptor activity is needed for consumption behavior in the anterior portion of the
NAc. Both D1 and D2 receptor activities are needed for the expression of fear
behaviors in the posterior NAc (Richard & Berridge, 2011). In addition, the VTA also
projects to the dorsal striatum through the nigrostriatal pathway (Abraham et al., 2014).
Dopaminergic neurons within the dorsal striatum are needed for discriminative reward
learning (Eagle, Olumolade, & Otani, 2015). It has also been demonstrated that
cocaine administration leads to plasticity in the VTA to medial NAc pathway, and
painful injection, such as formalin leads to plasticity in the VTA to mPFC pathway
(Lammel et al., 2014). Taken together, these data suggests that dopamine signaling is
implicated in both fear and reward learning.
Dopamine in Learning
Dopamine is critical for both LTP and LTD in certain brain structures. In the
striatum, D1 is necessary for LTP and D2 is necessary for LTD (Schultz, 2013). The
VTA also provides necessary dopamine signals to other downstream structures such as
PFC, amgydala and NAc contributing to different aspects of fear learning. D1 receptor
activity in the amygdala is critical for fear learning (Abraham et al., 2014). D1 receptor
activity in the dorsal hippocampus and BLA are necessary for the acquisition of
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contextual fear conditioning(Heath et al., 2015). In addition, restoring dopamine
function in the NAc and BLA in mice with impaired dopamine synthesis can rescue
impairments in long term memory of fear potentiated startle. This demonstrated that
dopamine signaling in the NAc and BLA is necessary for forming long term memory
of fear potentiated startle (Fadok, Darvas, Dickerson, & Palmiter, 2010). Dopamine is
also involved with fear extinction. Dopamine levels in the PFC typically increase
during fear extinction training. Blocking D1 receptor activity after or blocking D2
receptor activity before extinction training in the IL impairs fear extinction
consolidation (Abraham et al., 2014).
Dopamine D1 signaling in the amygdala, Nac, PFC and hippocampus, are
implicated in reward learning. D1 receptor activity in the NAs, dmPFC and BLA is
necessary for the reinstatement of drug seeking during stress(Tobin, Sedki, Abbas, &
Shalev, 2013). D1 receptor activity in the BLA, CeA, and ventral subiculum of the
hippocampus is necessary for the acquisition of conditioned approach behavior
(Matthew E. Andrzejewski & Ryals, 2016). D1 receptor activity in the BLA and CeA
is needed for the acquisition of conditioned lever press (M. E. Andrzejewski, Spencer,
& Kelley, 2005).
Dopamine release in the NAc is also important in reward learning.
Inappropriate dopamine release in the NAc is linked to drug abuse (Lammel et al.,
2014). NAc dopamine release is modulated by learning. It has been shown that
learning results in a larger dopamine release, but overtraining decreases the learning
related facilitation in dopamine release(A. L. Collins et al., 2016). During
discriminative reward learning, the NAc also shows a pattern of enlarged dopamine
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release to the discriminative stimulus (Jones et al., 2010). This learning related increase
in dopamine level in the NAc is amygdala dependent, and it can directly affect rewardseeking behavior. Ipsilateral BLA inactivation prior to training can diminish the
learning related increase in dopamine level to the discriminative stimulus and also
impaired approach behavior to the port (Jones et al., 2010).
There is a glutamatergic projection from the BLA to NAc. Optical activation of
this pathway is reinforcing because rats will learn to enter the port for the optical
stimulation of this pathway. Optical inhibition of the same pathway decreased cue
driven reward consumption(Stuber et al., 2011). D1 receptor activity in the NAc is
needed for the stimulation to be effective because animals with D1 antagonist infusion
into the NAc showed a decrease in cue-driven nose poke activity to the active port
(Stuber et al., 2011). This demonstrated that the optical induction of reward seeking
behavior is mediated by dopamine D1 receptor activity in the BLA-NAc projection.
Taken together, dopamine signaling from the VTA affects a wide range of brain
structures in regulating both reward and aversive learning.
Fear Conditioning
In Pavlovian fear conditioning, the conditioned stimulus (CS) signals the
occurrence of a threat(LeDoux, 2014). The CS is usually a tone or light and the threat
US is usually a mild footshock. The repeated pairing of the two results in a learned
defensive response to the CS in anticipation to the threat (LeDoux, 2014). For an
auditory CS, sensory information travels from the inferior colliculus (IC) through the
posterior intralaminar (PIN) and medial division of medial geniculate nucleus (MGm)
into the LA (Pape & Pare, 2010). It can also travel indirectly from MGm or ventral
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division of medial geniculate nucleus (MGv) to LA through the auditory cortex (Herry
& Johansen, 2014). US information travels from the spinal/trigeminal dorsal horn
through the PAG and converges with CS information in the LA (Herry & Johansen,
2014). Fear learning induces plasticity within the LA prior to the observed CS
facilitation in auditory cortex and auditory thalamus. The facilitation in LA is
associative because paired training leads to higher CS responding than unpaired
presentations. Even in discrimination training, CS facilitation in LA is only observed
toward CS and not to the CS- that signals the absence of the US (D. R. Collins & Paré,
n.d.). The LA has indirect projections to the CEm via the CEl, BA and ITC cells(Pape
& Pare, 2010). During fear consolidation and reconsolidation, theta activity has been
shown to synchronize between the dorsal hippocampus (CA1) and BLA. This CA1BLA activity is then phase locked with the IL during fear extinction (Lesting et al,
2011; Sangha et al 2009; Narayanan et al 2008). Lastly, CEA output is necessary for
producing different conditioned fear behaviors. Outputs to the lateral hypothalamus
and PAG selectively affects blood pressure and conditioned freezing,
respectively(LeDoux, Iwata, Cicchetti, & Reis, 1988).
Reward Conditioning
There is no standard behavioral paradigm for studying reward learning.
However, reward learning typically contains a CS such as a tone or light that signals
the occurrences of a reward delivery, or signals an opportunity that executing a certain
behavior results in the delivery of reward. Reward learning is an amygdala dependent
activity. While the CEA is required for reward learning that involves forming
associations between the CS and a broader anticipatory response such as approach
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behavior, arousal, and changes in heart rate (Balleine & Killcross, 2006), the BLA is
required for reward learning that involves forming associations between the CS and the
specific aspects of US consumption responses, such as licking and chewing (Balleine
& Killcross, 2006). The BLA is also needed when a specific reward outcome is
required to guide the operant response (Wassum & Izquierdo, 2015). Although lacking
evidence, it has been suggested that the general arousal and anticipatory responses
mediated by the CEA may facilitate US specific reward learning that is BLA-mediated
(Balleine & Killcross, 2006). In addition, the BLA has projections to other brain
structures that can influence different aspects of reward learning. Projections to the
dorsal medial striatum (DMS) and insular cortex affect learning of operant responseoutcome association. Projections to the OFC affect impulsivity, and disruption in this
pathway shifts the preference to choosing a smaller and quicker reward over a larger
delayed reward(Wassum & Izquierdo, 2015).
Conditioned Inhibition
A conditioned inhibitor is an inhibitory CS that signals the absence of the US.
It is distinguished from the lack of excitation in that it is an active suppression process
(Schwartz, Wasserman, & Robbins, 2002) that must pass both a summation test and
retardation test(J. P. Christianson et al., 2012). In contrast, a conditioned exciter
signals the occurrence of the US. This allow the animal to anticipate in advance. A
summation test can be performed by presenting a compound stimulus consisting of
both the conditioned exciter and conditioned inhibitor. The compound stimulus should
elicit a smaller magnitude of conditioned responding than conditioned exciter alone.
The retardation test uses the conditioned inhibitor as a conditioned exciter to be paired
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with the US. Pairing the US with the previously used inhibitor should result in slower
learning (J. P. Christianson et al., 2012).
Safety Conditioning
Safety cues signal the absence of a threat. This can be induced with unpaired
training, backward conditioning, discrimination training or avoidance training (Kong et
al., 2014). A learned safety cue is a type of conditioned inhibitor and is an active fear
suppressor that can be verified with the summation and retardation tests (J. P.
Christianson et al., 2012). In addition, since the fear and reward systems reciprocally
suppress each other, suppression of fear via a safety cue will indirectly excite the
reward system (Dickinson & Michael, 1979; Dickinson & Pearce, 1977; Gray, 1987),
providing learned safety cues with reinforcing properties (J. P. Christianson et al.,
2012). It has been demonstrated that animals would preferentially spend more time in
the chamber that has a safety signal playing (Rogan, Leon, Perez, & Kandel, 2005). In
addition, animals will preferentially choose a lever that also delivers the safety signal
when provided with two levers that can both prevent shock occurrence (A. B. P.
Fernando, Urcelay, Mar, Dickinson, & Robbins, 2014). Presenting a safety signal has
been shown to encourage exploratory behavior to the aversive center region in an open
field task (Rogan et al., 2005) and safety conditioning has been shown to rescue
impairments in social exploration resulting from prior exposure to inescapable tail
shocks(J. P. Christianson et al., 2008).
The amygdala and striatum have opposing functions in safety and fear learning.
Imaging studies have identified that the amygdala shows more activity to the fear CS
and a decrease in blood oxygenation level dependent activity to the safety CS. The
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striatum shows the opposite, with more activity to the safety CS and increased blood
oxygenation level dependent activity to the safety CS (Kong et al., 2014). This is
consistent with electrophysiological data demonstrating that the LA shows decreases in
CS evoked field potential amplitude and slope during safety training, and an increase in
CS evoked field potential amplitude and slope during fear training (Rogan et al., 2005).
This study also demonstrated that the caudoputamen(CP) shows an increase in CS
evoked field potential amplitude and slope during safety training, but no change to fear
conditioning. The SI is another area critical for safety expression. It has projections
to the amygdala (John P Christianson & Greenwood, 2014). . The hippocampus may
be another structure critical for safety. There is evidence that neurogenesis within the
hippocampus is necessary for safety conditioning (Pollak et al., 2008). In addition,
lesion studies have demonstrated that NAc is not necessary for safety learning and
expression(Josselyn, Falls, Gewirtz, Pistell, & Davis, 2005). However, this structure
still plays a role in expressing the rewarding effects of a safety cue. Both damphetamine or GABA antagonist administration into the NAs reduces avoidance
lever pressing in the presence of a safety cue, demonstrating NAs’s role in modulating
avoidance behaviors that is reinforced by safety signals (A. B. Fernando, Urcelay, Mar,
Dickinson, & Robbins, 2014). The PFC also receives considerable attention for safety
learning. Among people with PTSD, their impairment in safety learning has been
attributed hypoactivity in the PFC along with hyperactivity in the amygdala (J. P.
Christianson et al., 2012). Patients with generalized anxiety disorder also show lower
activity in the vmPFC than control patients to an aversive tone during discrimination
learning(Laufer, Israeli, & Paz, 2016). The IL within this structure is also necessary
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for fear extinction(Kong et al., 2014). However, the role of PFC on safety learning has
been controversial.

There is a group that found that inactivating both the PL and IL

together during safety learning does not impair the safety effect showing that the
ventromedial prefrontal cortex is not needed for safety learning(J. P. Christianson et
al., 2008). However, there is a different group that found that inactivating the IL and
PL separately revealed the IL is necessary for fear and safety discrimination
learning(Sangha, Robinson, et al., 2014).The discrepancy could be due to differences
in training paradigms. It is possible that inactivation both IL and PL concurrently
could have also impair fear expression since the PL and IL have differential roles in
fear expression and safety learning, respectively.
Different Than Extinction
In fear extinction, a previously learned CS is no longer followed by the US. As
a result, the animals gradually show less conditioned fear responses to the CS.
However, this fear reduction in fear extinction have distinct impacts and mechanisms
than that of learned safety. Fear extinction only inhibits fear to the once previously
conditioned signal. In contrast, learned safety has broader antidepressant and reward
effects because it can inhibit innate fear and facilitate reward behaviors(Kong et al.,
2014). These two types of learning are mediated by distinct neural circuits.
Electrophysiological data from the BLA have demonstrated the presence of
neurons that are responsive to the safety cue, combined fear + safety cue and reward
cues in the BLA indicating that the BLA has an overlapping neural circuit encoding
safety and reward learning (Sangha et al., 2013), further supporting an old idea that a
safety cue has rewarding properties (Rescorla, 1969). As a result, unlike extinction, the
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presence of safety cues can elicit approach behaviors and facilitate the acquisition of
operant tasks (J. P. Christianson et al., 2012). In addition, the number of BLA neurons
that show selective responding to the fear cue normally increase during
extinction(Sangha, 2015). However, the proportion of neurons within the BLA that
switch to become fear cue responsive does not differ between safety neurons and other
neurons during fear extinction(Sangha, 2015). This demonstrates that safety learning
and fear extinction likely involve independent circuits within the BLA.
Taking everything together, these findings suggest that dopamine signaling
within the BLA should modulate safety-fear-reward cue discrimination. Since there is
a high concentration of D1 receptors, but little to no expression of D2 receptors, in the
BLA (Abraham et al., 2014; Weiner et al., 1991), the current project focuses on the
effect of manipulating D1 receptor activity within the BLA.
Our program’s long-term goal is to better understand comorbid disorders
arising from emotional dysregulation. Our objective in this study is to identify the
contribution of BLA dopamine D1 receptor activity in mediating safety-fear-reward
cue discrimination using a rodent model. Our central hypothesis is that dopaminergic
D1 receptor activity in the BLA is essential for safety-fear-reward cue discrimination.
Our rationale for this research is to guide future research to better target the necessary
pathway(s) to manipulate and electrophysiologically monitor. This is essential for
linking cellular level changes to behavioral expression. We propose to test our central
hypothesis with the following two aims:
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Specific Aims

Aim 1. Hypothesis: A) Since dopamine D1 receptor activity in
the amygdala, NAc, and hippocampus mediates fear learning(Fadok et
al., 2010; Heath et al., 2015), increasing dopamine D1-receptor
activity globally with an agonist should enhance fear learning and
impair safety learning. Decreasing D1 receptor activity with an
antagonist globally should produce the opposite effect of enhancing
safety learning and impairing fear learning. B) Since dopamine D1
receptor activity in the PFC, NAc, amygdala and hippocampus mediates
reward learning(Matthew E. Andrzejewski & Ryals, 2016; Tobin et al.,
2013), increasing dopamine D1 receptor activity globally with an
agonist should enhance discriminative reward seeking. Blocking
dopamine D1 receptor activity globally with an antagonist should
produce the opposite effect of impairing discriminative reward
learning. This will be tested by using subcutaneous administration of a
D1 receptor agonist, D1 receptor antagonist or saline 20 minutes prior to
each discrimination session where rats are learning about cues signifying
safety, fear or reward using the procedure previously published (Sangha
et al., 2013; Sangha, Robinson, et al., 2014). In contrast to only
administering the drug prior to the last discrimination session,
administrating the drug prior to each discrimination session allows us to
examine the drug’s impact during discrimination acquisition.
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Aim 2. Hypothesis: Dopamine D1 receptor activity in the BLA is
needed for both fear learning (Heath et al., 2015) and reward learning
(Matthew E. Andrzejewski & Ryals, 2016). Dopamine levels in the BLA
increase during fear learning (de Oliveira et al., 2011), and BLA neurons
contribute to encoding reward prediction error (Wassum & Izquierdo,
2015). Increasing dopamine D1-receptor activity in the BLA with
an agonist should enhance fear learning and impair safety learning,
whereas decreasing BLA D1 receptor activity with an antagonist
should enhance safety learning and impair fear learning. In
addition, increasing dopamine D1 receptor activity in the BLA with
an agonist should enhance discriminative reward seeking, while
blocking dopamine D1 receptor activity in the BLA with an
antagonist should impair discriminative reward learning. This will
be tested by local BLA infusions of a D1 receptor agonist, D1 receptor
antagonist or saline 20 minutes prior to each discrimination session
where rats are learning about cues signifying safety, fear or reward using
the procedure similar to Aim 1.

For both Aims 1 and 2, it is predicted that fear/safety discrimination will be
impaired when D1 receptor activity is induced with an agonist. In addition, fear
learning and discriminative reward activity is expected to be impaired when D1
receptor activity is blocked with an antagonist in the BLA.
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MATERIALS AND METHODS

Subjects
Fifty-four Long Evans male rats (Harlan) weighing 300-350 g were single
housed (12h light/dark cycle, lights on 09:00) and handled for 1 week before
commencing experiments. All procedures were performed during the light cycle and
approved by the Purdue Animal Care and Use Committee. Rats had ad libitum access
to food and water up until the first training session, when they were restricted to 20 g
of food per day for the remainder of the experiment.
Apparatus
Operant chambers were Plexiglas boxes (32 cm length x 25 cm width x 30 cm
height) encased in sound-attenuating chambers (Med Associates, ST Albans, VT). 10%
liquid sucrose was delivered through a recessed port 2 cm above the floor in the center
of one wall. Port entries and exits were monitored through an infrared beam. Two
lights (28v, 100mA) located 10.5 cm from floor on either side of the port served as the
20-s continuous light cue. A light (28v, 100 mA) 27cm above the floor on the wall
opposite the port provided constant illumination. Auditory cues were delivered via a
“tweeter” speaker (ENV-224BM) located 24 cm from the floor on the same wall as the
port. Footshocks were delivered through a grid floor via a constant current aversive
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stimulator (ENV-414S). A side video camera located on the door of the soundattenuating cubicle recorded the rat’s behavior for offline video analyses.
Surgery
Rats were anesthetized with isoflurane and stereotaxically implanted bilaterally
with stainless steel 27- gauge guide cannula dorsal to the BA (AP -2.2mm; ML +/-4.9;
DV -7.5). During infusions, 32 gauge needles extended 1 mm beyond the guide
cannulas into the BA. Rats were allowed 7 – 10 days to recover in which they had ad
libitum access to food and water. Stainless steel 32-gauge dummy cannulas were
inserted into the guide cannulas between infusions.
Behavioral Training Paradigm
The three cues signifying reward, fear or safety were a 20 s continuous 3 kHz
tone (70dB), a 20 s pulsing 11 kHz tone (200 ms on, 200 ms off; 70 dB), or a 20 s
continuous light (28V, 100 mA), respectively. The stimuli were not counterbalanced
for this study since our previous study did not find significant differences in
conditioned freezing among any of the cues (Sangha et al, 2013).
Rats were trained in 3 phases. Phase 1 consisted of a reward session
administered on 5 separate days. Each session had 25 paired presentations of a 20s
reward cue with a 3 s delivery of 10% sucrose solution (100 µL) into the port
accessible to the animals. Sucrose delivery commenced pseudorandomly 10 to 20 s
after reward cue onset. The intertrial interval (ITI) was 90 -130 s. Phase 2 consisted of
a single habituation session. Animals continued to receive 25 trials of reward cuesucrose pairings as well as 5 additional trials each of the fear cue presented alone and
safety cue presented alone (ITI, 90-130 s). This procedure allows the animals to
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habituate and reduce their baseline freezing to the novel cues but does not contain
enough presentations to produce latent inhibition. Phase 3 consisted of four sessions of
discrimination training. For each session, delivered on separate days, rats received: 15
trials of reward cue-sucrose pairings, 4 trials of fear cue-footshock pairings (20 s cue +
0.5 s, 0.45 mA footshock at cue offset), 15 trials of simultaneous presentation of the 20
s fear and safety cues without footshock, and 10 trials of the 20 s safety cue presented
alone without footshock (total 44 trials, ITI 100 – 140 s). Inclusion of trials where the
safety cue was presented alone was to provide the animal with additional trials with a
safety cue- no shock contingency and to assess if freezing developed to the safety cue.
Systemic Injections
Systemic s.c. injections of a D1 receptor agonist (10mg/kg SKF-38393)(Doty et
al., 1998; Inoue, Izumi, Maki, Muraki, & Koyama, 2000), antagonist (3. 33µg/kg SCH23390) (Sciascia, Mendoza, & Chaudhri, 2014)or saline were administered 20 m prior
to each DC session. Previous study have shown that systemic administration of SKF38393 can increase and systemic administration of SCH-23390 can decrease Ach
release in striatal neurons in as little as 20 minutes, respectively (Johnson & Bruno,
1995). This provides support that our 20 minute wait time after systemic injection
should be sufficient to allow both the D1 receptor agonist and antagonist to reach the
brain. To acclimate the animals to the injection procedure, all rats also received saline
injections 20 minutes prior to the last reward training and habituation training.
BLA Infusions
D1 dopamine receptor agonist SKF38393 was dissolved in 0.9% sodium
chloride with concentrations of 1 μg/0.5μL (Zarrindast, Rezayof, Sahraei,
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Haeri-Rohani, & Rassouli, 2003). The antagonist SCH 23390 was dissolved in 0.9%
sodium chloride with concentrations of 0.25 μg/0.5μL (Hikind & Maroun, 2008).
Twenty minutes prior to each DC session, 0.5 µL of the mixture was infused (0.25
μL/s) into the BLA bilaterally. The injectors were left in place for 2 min post-infusion
to allow for drug diffusion. A separate group of animals received saline infusions
instead. In order to habituate animals to the infusion procedure, all animals received
sham infusions 20 min prior to the last reward session and habituation session.
Histology
Rats were deeply anesthetized with sodium pentobarbital, and then perfused
with PBS followed by 10 % formalin. Tissues were then post-fixed in 30% sucrose
formalin and sectioned at 50 µm with a cryostat. Sections were then plated on glass
slides and stained with cresyl violet. Slides were examined under a light microscope to
verify placements. 27 out of 48 rats had verified bilateral cannula placements in the
BLA and only these subjects were included in the analyses.
Data Analysis
Fear behavior was assessed offline from videos by measuring freezing, defined
as complete immobility with the exception of respiratory movements, which is an
innate defensive behavior (Blanchard & Blanchard, 1969; Fendt & Fanselow, 1999).
The total time spent freezing during the presentation of each 20 s cue was quantified.
Measuring the total time the animal spent inside the reward port and at the entrance of
the port with nose positioned at port entrance to assess reward behavior. We also
calculated a fear discrimination ratio (% Freezing to the fear cue/ (% Freezing to the
reward cue + % Freezing to the safety cue + % Freezing to the fear + safety cue)) and
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reward discrimination ratio (% Port to the reward cue / (% Port to the fear cue + % Port
to the safety cue + % Port to the fear + safety cue)) for each animal and each session.
Six individuals blind to drug treatment and cannula placement performed the
behavioral scoring. Pearson’s correlations of freezing and reward behavior values
between scorers were greater than r = 0.80. Behavioral data were analyzed with two
way ANOVAs followed by Dunnett’s post-hoc tests with GraphPad Prism. In our
discrimination paradigm, saline animals typically start to show evidence of safety
learning during DC3, with maximal discrimination among the different cues evidient in
DC4 (Sangha, Robinson, et al., 2014). Thus, we focused on testing for behavioral
differences in DC4. In contrast, using repeated measures among all four DC sessions
increases the number of unnecessary comparisons and compromising the likelihood of
detecting the learning related effect in the last session. We anticipated that the animals
will show more freezing to the fear cue than all other cues, and will show more port
activity to the reward cue than all other cues. In order to reduce numbers of
unnecessary comparisons, we used Dunnett’s test instead of Tukey to selectively
compare the activity to a specific cue against all other cues.
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RESULTS
Locomotor Effects of the D1 Receptor Agonist and Antagonist
To examine possible locomotor impairment from systemic or local
administration of D1 receptor agonist, D1 receptor antagonist or saline, we analyzed
the motion activity in the first and last five minutes of each session. The five minutes
windows were chosen because the number five is a prime number and its multiple is
easy to work with for potential normalizing or comparison. Analyzing the last five
minutes allows us to verify the duration of action of the drug throughout the entire
training session. If a drug influence locomotor activity in the first 5 minutes, we expect
it should have the same influence in the last 5 minutes.
Systemic Injection
A two way repeated measures ANOVA (time by treatment) was performed on
motion activity during the first and last five minutes of each DC session to look at the
effect of drug on locomotor activity. There was a significant main effect of time across
all DC sessions (DC1: F(1, 24) = 80.98, p < 0.0001; DC2: F(1, 24) = 79.05, p <
0.0001); DC3: F(1, 24) = 74.32, p < 0.0001; DC4: F(1, 24) = 76.83, p < 0.0001). Post
hoc comparison with Bonferroni correction showed that animals from each treatment
condition exhibited more locomotor activity in the first five minutes than the last five
minutes (p < 0.05). Since this effect was also seen in the saline group, this effect is
most likely due to reduced exploration of the conditioning chamber over time. There
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was also a significant main effect of treatment in DC4 (F(2, 24) = 4.36, p < 0.05), but
not DC1, 2 or 3. Post hoc comparison with Bonferroni correction showed that saline
animals had more locomotor activity than antagonist animals in the last 5 minutes (p <
0.05) for only DC4. This reduction in locomotor activity from the antagonist could
lead to the artificial increase in freezing score to all cues toward the end of DC4.
Taken together, these data indicate that systemic administration of D1 receptor agonist
or antagonist does not affect overall locomotor activity.
BLA Infusion
A two way repeated measures ANOVA (time by treatment) was performed on
motion activity during the first and last five minutes of each DC session to look at the
effect of drug on locomotor activity. There was a significant main effect of time across
all DC sessions (DC1: F(1, 24) = 44.67, p < 0.0001; DC2: F(1, 24) = 55.1, p < 0.0001);
DC3: F(1, 24) = 80.41, p < 0.0001; DC4: F(1, 24) = 138.1, p < 0.0001). Post hoc
comparison with Bonferroni correction showed that animals from each treatment
condition exhibited more locomotor activity in the first five minutes than the last five
minutes (p<0.05). Similar to what was seen with systemic injections, since this effect
was also seen in the saline group, this effect is most likely due to reduced exploration
of the conditioning chamber over time. No main effects of treatment were found.
These data indicate that BLA infusion of D1 receptor agonist or antagonist has no
effect on overall locomotor activity.
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Systemic Injection of D1 Receptor Agonist or Antagonist Blocks
Fear and Safety Discrimination
Twenty minutes prior to the start of each discrimination training session, rats
received a systemic injection of a D1 receptor agonist (10mg/kg SKF-38393; N = 8),
antagonist (3. 33µg/kg SCH-23390; N = 7) or saline (N = 12). During discrimination
training, rats were presented with cues signifying fear, reward, safety and the combined
fear + safety. The percent time spent freezing for each cue was calculated (Figure 2),
as well as the percent time spent in the port in response to each cue (Figure 3). Since
asymptotic level of learning occurred during the last session of discrimination training,
current analysis will focus on DC4. Two-way ANOVAs on percent time spent freezing
for each cue during DC4 (Figure 2) showed significant cue by treatment interactions
(F(6, 72) = 2.54, p < 0.05). A main effect of cue was found for DC4( F(3, 72) = 299, p
< 0.0001). Post hoc Dunnett’s multiple comparisons to the fear cue showed that saline
treated animals displayed significantly more freezing to the fear cue than all the other
cues (p < 0.05 each), indicating good fear discrimination. Animals with systemic
injections of the D1 receptor agonist or antagonist showed more freezing to the fear cue
than the reward cue and safety cues (Dunnett’s multiple comparison to fear cue, p <
0.05 each). However, neither group showed significantly more freezing to the fear cue
than the combined fear + safety cue (p > 0.05). This indicates that systemic injections
of a D1 receptor agonist or antagonist impair fear suppression in the presence of the
safety cue. A main effect of treatment was also found for DC4 (F(2, 24) = 14.95, p <
0.0001). Post hoc Dunnett’s multiple comparisons to the saline group showed that D1
receptor agonist treated group had higher levels of freezing to the reward, safety, and
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fear + safety cue than saline animals. Even though we previously reported that
antagonist animals had reduced locomotor activity toward the end of DC4, but current
results suggested that the reduced locomotor activity did not appear to increase freezing
scores in the antagonist group.
To further assess fear discrimination behavior, we also calculated
discriminative fear ratios for a broader comparison of freezing levels to the fear cue
relative to the sum of freezing to all other cues. The ratios were calculated for each
animal then averaged (Figure 2). A fear discrimination ratio larger than one indicates
more freezing to the fear cue than all other cues and would be indicative of good
discrimination. One-way ANOVAs on the fear discrimination ratios during DC4
showed a significant effect of treatment (F(2, 24) = 7.21, p < 0.01). Post hoc Dunnett’s
multiple comparisons to the saline group showed that fear discrimination ratios were
significantly lower in the D1 receptor agonist treated animals (p < 0.05) but not the D1
receptor antagonist treated animals (p > 0.05).
We have used two methods to quantify fear discrimination behavior: 1)
averaged percent time freezing to the fear cue versus the combined fear+safety cue
and, 2) within animal fear discrimination ratios of freezing to the fear cue compared to
all other cues. Fear discrimination, as assessed by comparing averaged percent time
freezing relative to the combined fear+ safety cue, was impaired by systemic injections
of either the D1 receptor antagonist and agonist. In addition, systemic injections of a
D1 receptor agonist significantly lowered the fear discrimination ratio. Taken together,
both the agonist and antagonist impair fear discrimination behavior.
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For the same DC4 session, discriminatory reward seeking was also analyzed.
Two-way ANOVAs on percent time spent in the port for each cue during DC4 (Figure
3) showed a significant cue by treatment interaction (F(6, 72) = 7.58, p < 0.001). A
main effect of cue was found for DC4 (F(3, 72) = 38.99, p < 0.0001). Post hoc
Dunnett’s multiple comparisons to the reward cue showed that the saline group showed
more port activity to the reward cues than all the other cues (p < 0.05 each), which was
also seen in the D1 receptor antagonist group (p < 0.05 each). The D1 receptor agonist
group did not show more port activity during the reward cue than all other cues (p >
0.05). These data indicate that systemic injection of a D1 receptor agonist decreased
discriminative port activity. A main effect of treatment was also found for DC4 (F(2,
24) = 7.52, p < 0.01 ). Post hoc Dunnett’s multiple comparisons showed that saline
animals had higher port activity to the reward cue than D1 receptor agonist treated
animals (p < 0.05).
Reward discrimination ratios were calculated using the ratio between port
activities in response to the reward cue versus the sum of port activity in response to
the other cues for each animal (Figure 3). One-way ANOVAs on reward
discrimination ratios for each DC session showed a significant treatment effect during
DC4 (F(2, 24) = 7.77, p < 0.01). Post hoc Dunnett’s multiple comparisons to the saline
group showed significantly lower reward discrimination ratios in the D1 receptor
agonist treated animals (p < 0.05) but not the D1 receptor antagonist treated animals (p
> 0.05). These data indicate that systemic injection of a D1 receptor agonist, but not
antagonist, impairs discriminative reward seeking.
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Systemic Injection of D1 Receptor Agonist or Antagonist During DC1-3
Systemic Freezing
There were significant cue by treatment interactions for sessions DC 2-3 (DC2:
F(6, 72) = 2.58, p < 0.05; DC3: F(6, 72) = 3.40, p < 0.01) , but not DC 1 (F(6, 72) =
2.07, p = 0.07). A main effect of cue was found for DC1-3 sessions (DC1: F(3, 72) =
40.38, p < 0.0001; DC2: F(3, 72) = 187.9, p < 0.0001; DC3: F(3, 72) = 249.1, p <
0.0001). Post hoc Dunnett’s multiple comparisons to the fear cue showed that saline
treated animals displayed significantly more freezing to the fear cue than all the other
cues (p < 0.05 each) during sessions DC2, and DC3. Animals with systemic injections
of the D1 receptor agonist or antagonist showed more freezing to the fear cue than the
reward cue and safety cues (Dunnett’s multiple comparison to fear cue, p < 0.05 each)
during sessions DC2 and DC3. However, neither group showed significantly more
freezing to the fear cue than the combined fear + safety cue (p > 0.05) during sessions
DC1, DC2, or DC3. A main effect of treatment was also found for DC1, 2 and 3.
(DC1: F(2, 24) = 6.30, p < 0.01, DC2: F(2, 24) = 8.11, p < 0.01, DC3: F(2, 24) =
12.36, p < 0.001). Post hoc Dunnett’s multiple comparisons to the saline group
showed higher levels of freezing to the fear cue in the saline group than the antagonist
group during DC1, DC2, and DC3. Saline animals showed lower levels of freezing to
the reward and safety cues than the D1 receptor agonist treated group during sessions
DC2 and DC3. One-way ANOVAs on the fear discrimination ratios during each DC
session showed a significant effect of treatment during DC2 (DC2: F(2, 24) = 4.72, p <
0.05), but not DC 1 or 3 (DC1: F(2, 24) = 0.39, p = 0.68; DC3: F(2, 24) = 2.40, p =
0.11). For DC2, post hoc Dunnett’s multiple comparisons to the saline group showed
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fear discrimination ratios were significantly lower in the D1 receptor agonist treated
animals (p < 0.05) but not the D1 receptor antagonist treated animals (p > 0.05).
Systemic Port
Two-way ANOVAs on percent time spent in the port for each cue during each
DC session (Figure 3) showed a significant cue by treatment interaction for DC1-3
(DC1: F(6, 72) = 3.11, p < 0.01; DC2: F(6, 72) = 2.56, p < 0.05; DC3: F(6, 72) = 7.93,
p < 0.001). A main effect of cue was found for DC1-3 (DC1: F(3, 72) = 46.95, p <
0.0001; DC2: F(3, 72) = 38.41, p < 0.0001; DC3: F(3, 72) = 22.29, p < 0.0001). Post
hoc Dunnett’s multiple comparisons to the reward cue showed that the saline group
showed more port activity to the reward cues than all the other cues (p < 0.05 each)
during DC1-3.The D1 receptor antagonist groups showed more port activity to the
reward cues than all the other cues during DC1 and 2 (p < 0.05 each), but not DC3 (p >
0.05). The D1 receptor agonist group did show more port activity during the reward
cue than all other cues (p < 0.05) during DC1, but not during DC2-3 (p > 0.05). A main
effect of treatment was also found for DC1-3 (DC1: F(2, 24) = 4.56, p < 0.05; DC2:
F(2, 24) = 7.48, p < 0.01; DC3: F(2, 24) = 19.87, p < 0.0001). Post hoc Dunnett’s
multiple comparisons to the saline group showed that saline animals had higher port
activity to the reward cue than D1 receptor agonist treated animals (p < 0.05) during
sessions DC1, DC2, and DC3. One-way ANOVAs on reward discrimination ratios for
each DC session did not show significant treatment effect during any DC1-3 (DC1:
F(2,24) = 1.83, p = 0.18; DC2: F(2, 24) = 0.83, p = 0.45; DC3: F(2, 24) = 1.91, p =
0.17).
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Taken together systemic injections of the D1 receptor agonist, SKF-38393, and
antagonist, SCH-23390, both impair suppression of freezing to the fear cue when in the
presence of the safety cue (Figure 2). The D1 receptor antagonist did not significantly
impair reward seeking during the reward cue when compared to the other cues. The D1
receptor agonist, however, did appear to significantly suppress reward seeking during
all cues (Figure 3). Since D1 receptor agonist animals did show a high level of
discriminative reward seeking behaviors and local motor activities during the first
session of discrimination, the observed impairment over subsequent days could be due
occlusion of reward seeking behavior. To minimize the negative influence of the nonspecific effects of the drugs on behavioral expression, the same drugs were infused
directly into the BLA in Experiment 2.
BLA Infusion of a D1 Receptor Agonist, but not Antagonist,
Impairs Discriminative Fear Learning
Dopamine signaling within the BLA has been implicated in fear learning, fear
extinction and reward learning. The systemic administration of D1 receptor agonist or
antagonist could be producing its impairment in fear suppression and reward seeking
by exerting its effects through the BLA. To localize the effect of D1 receptor activity,
twenty minutes prior to the start of each DC session, 0.5 µL of D1 receptor agonist (1
μg/0.5μL SKF-38393; N = 9), antagonist (0.25 μg/0.5μL SCH-23390; N = 8) or saline
(N = 10) were infused directly into the BLA bilaterally. Only animals with confirmed
bilateral placements of cannula tips in the BLA were included in the analyses (27 of 48
animals; Figure 4). During discrimination training, rats were presented with cues
signifying fear, reward, safety and the combined fear + safety. The percent time spent
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freezing for each cue was calculated (Figure 5), as well as the percent time spent in the
port in response to each cue (Figure 6).
Since asymptotic level of learning occurred during the last session of
discrimination training, current analysis will focus on DC4. Two-way ANOVAs on
percent time spent freezing for each cue during DC4 (Figure 5) showed significant
main effect of cue (F(3, 72) = 102.2, p < 0.001). Post hoc Dunnett’s multiple
comparisons to the fear cue showed that the saline group froze significantly more to the
fear cue in comparison to the other cues (p < 0.05). Similarly, the D1 receptor
antagonist group showed more freezing to the fear cue in comparison to the other cues
(p < 0.05). The D1 receptor agonist group, however, only showed more freezing to the
fear cue compared to the reward and safety cues, and not the fear+safety cue. Together
this indicates that BLA infusion of a D1 receptor agonist, but not antagonist, impairs
fear suppression in the presence of safety cue. A main effect of treatment was also
found for DC4 (F(2, 24) = 4.46, p < 0.05). Post hoc Dunnett’s multiple comparisons to
the saline group showed that D1 receptor agonist treated animals had higher levels of
freezing to the reward cue and to the safety cue. One way ANOVAs on fear
discrimination ratios for DC4 showed a significant main effect of treatment (F(2, 24) =
5.70, p < 0.01)). Post hoc Dunnett’s multiple comparisons to the saline group showed
that saline animals had higher fear discrimination ratios than agonist animals but not
antagonist animals in DC4. This indicates that infusion of the agonist directly into the
BLA impairs discriminative freezing to the fear cue relative to the other cues.
A two way ANOVA on percentage of time spent in the port (Figure 6) showed
a significant main effect of cue for DC4 (F(3, 72) = 20.86, p < 0.0001). Post hoc
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Dunnett’s multiple comparisons to the reward cue showed that the saline and
antagonist groups exhibited more port activity to the reward cue in comparison to the
other cues. The agonist group also showed more port activity to the reward cue than
the fear + safety and safety cues, but not the fear cue. One way ANOVAs on reward
discrimination ratios for each DC session showed no significant main effects of
treatment during DC4 ( F(2, 24) = 1.89, p < 0.17). Overall, this indicates that infusing
an agonist or antagonist into the BLA does not impair discriminative reward behavior.
BLA infusion of D1 Receptor Agonist or Antagonist During DC1-3
Infusion Freezing
Two-way ANOVAs on percent time spent freezing for each cue during DC 1- 3
(Figure 5) showed significant main effect of cue (DC1: F(3, 72) = 14.01, p < 0.0001;
DC2: F(3, 72) = 45.44, p < 0.0001; DC3: F(3, 72) = 55.17). Post hoc Dunnett’s
multiple comparisons to the fear cue showed that the saline group froze significantly
more to the fear cue in comparison to the other cues (p < 0.05) during sessions DC1
and DC3. A main effect of treatment was also found for DC1-3 (DC1: F(2, 24) = 4.75,
p < 0.05; DC2: F(2, 24) = 7.09, p < 0.01; DC3: F(2, 24) = 3.61, p < 0.05). Saline
treated animals showed more freezing to the fear cue than the reward cue and safety
cue during DC2. The D1 receptor antagonist group showed more freezing to the fear
cue in comparison to the other cues (p < 0.05) during DC2. This group also showed
more freezing to the fear cue than the reward cue and safety cue, but not the combined
fear + safety cue during DC3. The D1 receptor agonist group showed more freezing to
the fear cue than the reward cue and safety cue during DC1, DC2 and DC3. This group
also showed more freezing to the fear cue than the combined fear + safety cue during
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DC3, but not DC1 and DC2. Post hoc Dunnett’s multiple comparisons to the saline
group showed that D1 receptor agonist treated animals had higher levels of freezing to
the combined fear + safety cue than the saline group during DC1 and DC2. In
comparison to the saline group, the agonist group also showed higher levels of freezing
to the fear cue during DC2 and reward cue during DC3. The D1 receptor antagonist
group, on the other hand, showed less freezing to the fear cue than saline animals
during DC1. One way ANOVAs on fear discrimination ratios for each DC session
showed a significant main effect of treatment for DC2 (F(2, 24) = 3.45, p < 0.05) but
not DC1 and DC3 (DC1: F(2, 24) = 0.41, p = 0.67; DC3: F(2, 24) = 2.73, p = 0.09).
Infusion Port
A two way ANOVA on percentage of time spent in the port (Figure 6) showed
a significant main effect of cue for DC1-3 (DC1: F(3, 72) = 48.08, p < 0.001; DC2:
F(3, 72) = 41.92, p < 0.001; DC3: F(3, 72) = 16.24, p < 0.0001). Post hoc Dunnett’s
multiple comparisons to the reward cue showed that the saline and antagonist groups
exhibited more port activity to the reward cue in comparison to the other cues during
DC1, DC2 and DC3. The agonist group also showed more port activity to the reward
cue than the other cues during DC1 and DC2. This group also showed more port
activity to the reward cue than the fear + safety and safety cues, but not the fear cue,
during DC3. One way ANOVAs on reward discrimination ratios for each DC session
showed no significant main effects of treatment during DC1-3 (DC1: F(2, 24) = 0.81, p
= 0.46; DC2: F(2, 24) = 0.67, p = 0.52; DC3: F(2, 24) = 0.31, p = 0.74).
Taken together, the impairment in discriminative fear that was seen during
systemic injection of the D1 receptor agonist, SKF-38393, was replicated when the
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agonist was infused directly into the BLA. However, the D1 receptor antagonist, SCH23390, only had an effect on fear and safety discrimination during systemic
administration and not during direct BLA infusion. This indicates that the fear
discrimination impairment seen in the systemic D1 receptor antagonist group could be
having its effect on areas outside the BLA. In addition, the D1 receptor agonist only
had an effect on discriminative reward seeking when it was administered systemically
but not when it was directly infused into the BLA. This indicates that dopamine D1
receptor activity in the BLA is not critical for discriminative reward behavior.
Correlation of Movement With Fear Learning
To examine the possible relationship between contextual freezing and cue
induced conditioned freezing, correlation coefficient r was calculated for each
treatment condition to measure the strength of association between the first five minute
of locomotor activities and freezing to the fear cue in DC4. No significant correlation
was found for any of the treatment conditions in either systemic or BLA infusion
conditions in DC4.
Comparing Behavior Between the First Half and Second Half
of Each Discrimination Session
As an additional way to verify that the effect of the drugs last throughout the
entire training session, we also compare freezing level and port activity to each of the
cues between the first half and second half of each session. Dividing the time into first
half and second half of the session allow us to look at potential recovery of learning as
the drug effect reduces. Post hoc tests with Bonferroni corrections were used to
compare the differences in freezing or port levels among cues between the first half and
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the second half of each session. Post hoc Dunnett’s test was used to compare the
differences in percent time spent freezing among different cues against percent time
freezing to the fear cue. If there is an increase in generalized freezing to all cues from
the first half to the second half of the session, the main effect of time should be
statistically significant. In contrast, if there is a selective and discriminative increase in
freezing to the fear cue relative to other cues, the time by cue interaction should be
statistically significant. Post hoc Dunnett’s test was also used to compare the
differences in percent time spent on port activity among different cues against percent
time spent on port activity to the reward cue. Similar to freezing mentioned above,
increased in generalized port activity to all cues from first half to the second half of the
session should result in the main effect of time, and discriminative increase in port
activity to the reward cue relative to the other cues should lead to time by cue
interaction.
Discriminative Freezing After Systemic Injection
A two way repeated measures ANOVA (time by cue) was performed on percent
time spent freezing for each treatment condition during each DC session. The results
are summarized in Table 2. Saline animals showed a significant time by cue
interaction during DC1 and a significant main effect of time during DC1 and 2. These
results reflect within session learning because saline animals were not under drug
influence. They also showed more freezing to the fear cue in the second half than the
first half of the DC1. During DC3 and 4, saline animals no longer show significant
time by cue interactions or significant main effects of time, indicating that the
magnitude of freezing to the fear cue did not change during the first half to the second
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half of DC3 and DC4. Both agonist and antagonist animals showed significant time by
cue interactions and main effects of cues during DC1 indicating that changes in
freezing occurred within DC1. However, no significant time by cue interactions or
main effects of time during DC2 to 4 for either the agonist or antagonist animals were
observed, indicating that no detectable changes in freezing occurred within those
subsequent DC sessions.
Discriminative Reward Seeking After Systemic Injection
The same analyses done for percent time in port and the results are summarized
in Table 3. There was a significant main effect of time and time by cue interaction
during DC1 for saline animals, and DC1 and 2 for antagonist animals. Again, these
effects reflect within session learning during earlier DC sessions, but not in DC3 or 4.
Agonist animals showed significant cue by time interaction during DC2, and a main
effect of time during DC3. These indicate that the systemic administration of agonist
occludes the behavioral expression of port behavior. Agonist animals showed more
port activity to the reward cues than to some of the other cues only during the first half
of DC1 and DC2.
Discriminative Freezing After BLA Infusion
A two way repeated measures ANOVA (time by cue) was performed on percent
time spent freezing for each treatment condition during each DC session. The results
are summarized in Table 4. Saline animals showed significant cue by treatment
interaction during DC3 and 4, but not DC1 and 2. This again reflects within session
learning. Antagonist animals showed a significant cue by treatment interaction during
DC3 only. These indicate that there was some learning related changes during the later
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DC sessions. Agonist animals had a significant main effect of time in DC2 only. This
also reflects some within session learning in DC2.
Discriminative Reward Seeking After BLA Infusion
The same analyses were done for percent time in port and the results are
summarized in Table 5. No significant main effects of time or time by cue interactions
were detected for saline animals in any DC session. A main effect of time was
detected in antagonist animals during DC4. A significant main effect of time and time
by cue interaction was detected in agonist animals during DC2 only.
Summary
If the administered drug has a short lifespan, we expect to see significant cue by
time interaction with more freezing or port activity to the respective cues in the second
half than the first half of the session. An overall increase in freezing or port activity
from the first half of the session to the second half would be reflected as a main effect
of time, and a selective increase in freezing or port activity to the conditioned cue from
the first half to the second half would be reflected as a time by cue interaction.
Animals with systemic injections of the D1 receptor agonist or antagonist showed more
freezing to the fear cue than the reward cue and safety cues (Dunnett’s multiple
comparison to fear cue, p<0.05 each) during sessions DC2, DC3 and DC4. However,
neither group showed significantly more freezing to the fear cue than the combined
fear + safety cue (p>0.05) during sessions DC1, DC2, DC3, or DC4. These indicate an
impairment in fear suppression during DC2, 3 and 4. Since no significant main effect
of time or time by cue interaction was detected during those sessions for antagonist and
agonist animals, there were no within session changes. This suggests that the effects of
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the systemically administered drugs last throughout the entire two hour training
session. During BLA infusion, the D1 receptor agonist group showed more freezing to
the fear cue than the reward cue and safety cue during DC1, DC2, DC3 and DC4. This
group also showed more freezing to the fear cue than the combined fear + safety cue
during DC3, but not DC1, DC2 and DC4. Since no significant main effects of time or
time by cue interactions were detected for these animals during DC3 or 4, the effect of
BLA infused agonist persisted throughout the entire two hour training session. On the
other hand, BLA infusion of the antagonist did not produce any impairment in
conditioned freezing or reward seeking. The current within session analysis only
showed time by cue interaction in freezing activity during DC3, but not in any other
sessions. Overall, there are no evidence of the BLA antagonist effect diminishing in
the second half of the two hour training session.
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DISCUSSION

To investigate BLA dopamine D1 receptor activity in mediating fear-rewardsafety discrimination learning, we hypothesized that increasing dopamine D1 receptor
activity in the BLA should impair fear/safety discrimination learning, enhance fear
learning, and enhance discriminative reward seeking. Decreasing dopamine D1
receptor activity in the BLA should impair fear learning, enhance fear/safety
discrimination learning and impair discriminative reward seeking. Animals that
received a systemic injection or BLA infusion of saline showed good discrimination
learning: they froze more to the fear cue and spent more time at the port during the
reward cue compared to the other cues. Since saline animals showed more freezing to
the fear cue than the combined fear + safety cue, they demonstrated learned safety by
suppressing fear in the presence of the safety signal. These are consistent with
previous findings (Sangha et al., 2013; Sangha, Greba, Robinson, Ballendine, &
Howland, 2014; Sangha, Robinson, et al., 2014). In addition, the systemic injection of
a D1 receptor agonist or antagonist blocked fear/safety discrimination learning.
Systemic administration of the agonist, but not antagonist, also impaired the
discriminative fear and reward ratios. When the agonist was infused directly into the
BLA, we replicated the impairments in fear/safety discrimination and the
discriminative fear ratio, but not the impairment in discriminative reward seeking.

42
BLA infusion of the antagonist had no effect on the fear/safety discrimination, fear
discrimination ratio or discriminative reward seeking. These data support our
hypothesis that increasing dopamine D1 receptor activity in the BLA impairs fear and
safety discrimination behavior. However, our data does not support the hypothesis that
decreasing dopamine D1 receptor activity impairs discriminative reward seeking
behavior.
Taken together, these data suggest that dopamine D1 receptor activity in the
BLA is not necessary for discriminative reward seeking, safety learning or
discriminative fear learning. Blocking D1 receptor activity in the BLA with a D1
receptor antagonist did not impair discriminative reward seeking, fear and safety
discrimination or discriminative fear learning. However, increasing D1 receptor
activity, either systemically or directly in the BLA, impairs fear and safety
discrimination. We found a similar impairment in the discriminative fear ratio when
comparing freezing behavior to the fear cue against freezing behavior to all other cues
regardless if the agonist was administered systemically or infused locally in the BLA.
Animals that received systemic or BLA administration of the agonist were still able to
show more freezing to the fear cue than the reward and safety cues, demonstrating
some level of fear discrimination. However, these animals did not show increased
freezing to the fear cue relative to the fear+safety cue, demonstrating a selective
impairment in suppressing freezing to the fear cue in the presence of the safety cue.
This impairment in fear suppression may be due to increased activity in the amygdala
through D1 receptor activation. Since the amygdala typically shows a higher CS
evoked field potential to a fear CS compared to a safety CS (Rogan et al., 2005), the
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stimulation of D1 receptors may prevent the necessary decrease in amygdala activity
during safety learning, leading to behavioral impairments in safety but not fear
behavior. Increasing D2 receptor activity in the VTA blocks learning related increases
in dopamine levels within the BLA during fear conditioning (de Oliveira et al., 2011),
implying that BLA dopamine levels are mediated by the VTA.
The impairment in fear and safety discrimination with a systemic D1 receptor
antagonist injection was due to impairment in safety learning since animals were still
able to showing discriminative fear with respect to both the reward cue and safety cue
during discrimination training session two, three and four. D1 receptor antagonist
systemic drug action could be acting through the PFC to produce impairment in safety
discrimination. The IL is necessary for fear and safety discrimination(Sangha,
Robinson, et al., 2014) and it receives dopaminergic projection from the VTA
(Abraham et al., 2014) as well as projecting directly to the BLA (Vertes, 2004). D1
receptor activity in the IL is necessary for fear extinction consolidation(Abraham et al.,
2014). The systemic administration of the D1 receptor antagonist could produce
receptor action in the IL leading to the impairment we observed in safety
discrimination.
For discriminative reward behavior, it appears that D1 receptor activity in the
BLA is not needed. Neither systemic nor BLA administration of the D1 receptor
antagonist had an effect on the reward discrimination ratio. The impairment we
observed in discriminative reward seeking with the systemically administered D1
receptor agonist is likely due to impairment in behavioral expression. These animals
showed discriminative port activity similar to saline and antagonist treated animals
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during the first discrimination training session. Then, all port activity diminished over
each subsequent session. This impairment in discriminative reward seeking is not due
to D1 receptor action in the BLA because BLA infusion of the D1 receptor agonist had
no effect on the discriminative reward ratio. The impairment could however be due to
receptor action in the NAc. D1 receptor activity in the NAc is necessary for
consumption behavior (Richard & Berridge, 2011) and the reinstatement of drug
seeking during stress (Tobin et al., 2013). Dopamine levels in the NAc also gradually
increase during different phases of operant behavior that lead to reward outcome(A. L.
Collins et al., 2016). This change in dopamine levels is influenced by the BLA and it
is D1 receptor activity dependent (Stuber et al., 2011). Activation of this pathway
induces reward seeking (Stuber et al., 2011) and inactivation of BLA using
muscimoml/baclofen mixture impairs approach behavior to the port (Jones et al.,
2010). In light of these findings, it is possible that increasing D1 receptor activity in the
NAc via a systemically administered D1 receptor agonist during reward seeking may
be reinforcing on its own and may occlude reward seeking behavioral expression.
Our current study indicates that increasing dopamine D1 receptor activity in the
BLA may be a potential mechanism that leads to the impairment in fear and safety
discrimination seen with PTSD patients. Since the VTA is the primary source of
dopamine for the BLA, the VTA might be providing safety information to the BLA.
The alteration in dopamine release in the VTA-BLA pathway may contribute to the
impairment in fear/safety discrimination in people with PTSD. Enhanced dopamine
release may occlude the necessary phasic increase in dopamine release in the VTABLA pathway during fear learning whereas decreased dopamine release may occlude
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the necessary phasic decrease in dopamine levels in the VTA-BLA pathway during
safety learning. This would indicate that the VTA-BLA dopamine signaling pathways
may be potential therapeutic target sites for treating PTSD.
Manipulating dopamine receptor activity has been reported to affect locomotion
activity(Pezze, Marshall, & Cassaday, 2016; Tran et al., 2005). To avoid this problem,
we used dosages that have been published by other labs using the same method of
administration as the current study. In addition, examining the first five minutes of
locomotor activity prior of each training session did not show impairment in
locomotion activity for any treatment conditions.
In conclusion, we have identified that increasing D1 receptor activity in the
BLA impairs fear/safety discrimination. Currently, it is unclear if inactivating the
dopaminergic pathway from the VTA to BLA drives safety behavior. It is also unclear
if increased dopamine D1 receptor activity in the NAc interferes with reward seeking.
Future studies will use a retro-DREADD approach to activate the VTA to BLA
dopamine pathway during fear, safety and reward discrimination to assess if the same
impairment in fear/safety discrimination is observed. Future studies can also use retroDREADDs to activate the BLA to NAc pathway during fear, safety and reward
discrimination to investigate if it impairs reward seeking. An impairment would
indicate the decrease in reward seeking seen during systemically administered D1
agonist is being mediated by the BLA-NAc pathway.
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Table 2
Comparison of Freezing Percentage to Each of the Cues Between the First Half and
Second Half of Each DC Session for Animals That Received Systemic Administration of
D1 Receptor Agonist, D1 Receptor Antagonist, or Saline
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Table 3
Comparison of Port Percentage to Each of the Cues Between the First Half and
Second Half of Each DC Session for Animals That Received Systemic Administration of
D1 Receptor Agonist, D1 Receptor Antagonist, or Saline
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Table 4
Comparison of Freezing Percentage to Each of the Cues Between the First Half and
Second Half of Each DC Session for Animals That Received BLA Infusion of D1
Receptor Agonist, D1 Receptor Antagonist, or Saline
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Table 5
Comparison of Port Percentage to Each of the Cues Between the First Half and
Second Half of Each DC Session for Animals That Received BLA Infusion of D1
Receptor Agonist, D1 Receptor Antagonist, or Saline
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Appendix B

Figure 1. Wiring diagram for critical structures with upstream projections to the BLA
(color red) and output projection from the BLA (color blue). Structures with reciprocal
projection with the BLA are colored green.
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Note. (A) Animals received 5 sessions of paired reward trainings followed by habituation and
discrimination trainings. 20 minutes prior to the start of discrimination trainings, animals received either
systemic administration of D1 receptor agonist, antagonist or saline. To habituate the animals to the
injection procedure, saline injections were given 20 minutes prior to the last session of reward and
habituation session. (B-E, left panels) Saline treated animals (n = 12) show good fear discrimination.
They showed more % freezing to the fear cue than all the other cues during sessions DC2, DC3 and
DC4. Systemic injections of a D1 receptor agonist (10mg/kg SKF-38393; N = 8) or antagonist (3.
33µg/kg SCH-23390; N = 7) impair fear suppression in the presence of the safety cue. Animals with
systemic injections of the D1 receptor agonist or antagonist showed more % freezing to the fear cue than
the reward cue and safety cues during sessions DC2, DC3 and DC4. However, neither group showed
significantly more % freezing to the fear cue than the combined fear + safety cue during sessions DC1,
DC2, DC3, or DC4. (B-E, right panels) The fear discrimination ratio was only impaired in agonist
treated animals. For sessions DC2 and 4, D1 receptor agonist treated animals, but not the D1 receptor
antagonist treated animals, had significantly lower fear discrimination ratios than saline animals.

Figure 2. Freezing behavior after systemic injection of dopamine D1 receptor agonist,
antagonist or saline.
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Note. (A) Training and injection paradigm is same as data presented in Figure 2. (B-E, left panels)
Discriminative port activity to the reward cue is learned early. Animals in all treatment conditions
showed more % port to the reward cue than all other cues during DC1. Systemic injection of a D1
receptor agonist (10mg/kg SKF-38393; N = 8), but not antagonist (3. 33µg/kg SCH-23390; N = 7),
impairs discriminative reward seeking. Systemic injection of a D1 receptor agonist decreased % port
over subsequent days of training during DC2-4. On the other hand, saline treated animals showed more
% port to the reward cues than all the other cues during every DC session. The D1 receptor antagonist
groups showed more % port to the reward cues than all the other cues during DC1, 2 and 4, but not DC3.
(B-E, right panels) The reward discrimination ratio was only impaired for D1 receptor agonist treated
animals not the D1 receptor antagonist during session DC4 compare to saline animals.

Figure 3. Port percentage after systemic injection of dopamine D1 receptor agonist,
antagonist or saline.
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Figure 4. Placement of infusion needle tips for BLA infusion of dopamine D1 receptor
agonist, antagonist or saline. Only animals with confirmed bilateral hits were included
in the analysis.
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Note. (A) Animals received 5 sessions of paired reward trainings followed by habituation and
discrimination trainings. 20 minutes prior to the start of discrimination trainings, animals received either
BLA infusion of D1 receptor agonist, antagonist or saline. To habituate the animals to the infusion
procedure, sham infusions were given 20 minutes prior to the last session of reward and habituation
session. (B-E, left panels) Saline treated animals (N = 10) are showing good fear discrimination. Saline
group froze significantly more to the fear cue in comparison to the other cues during sessions DC1, DC3
and DC4. Saline treated animals also showed more % freezing to the fear cue than the reward cue and
safety cue during DC2. BLA infusion of a D1 receptor agonist (1 μg/0.5μL SKF-38393; N = 9), but not
antagonist (0.25 μg/0.5μL SCH-23390; N = 8), impairs fear suppression in the presence of safety cue.
The D1 receptor agonist group showed more % freezing to the fear cue than the reward cue and safety
cue during DC1, DC2, DC3 and DC4. This group also showed more % freezing to the fear cue than the
combined fear + safety cue during DC3, but not DC1, DC2 and DC4. In addition, the D1 receptor
antagonist group showed more % freezing to the fear cue in comparison to the other cues during DC2
and DC4. This group also showed more % freezing to the fear cue than the reward cue and safety cue,
but not the combined fear + safety cue during DC3. (B-E, right panels) The fear discrimination ratio
was only impaired for agonist animals. During DC2 and DC4, that saline animals had higher fear
discrimination ratios than agonist animals but not antagonist animals in DC4.

Figure 5. Freezing percentage after BLA infusion of dopamine D1 receptor agonist,
antagonist or saline.
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Note. (A) Training and injection paradigm is same as data presented in Figure 5. (B-E, left panels)
Infusion of D1 receptor agonist (1 μg/0.5μL SKF-38393; N = 9) or antagonist (0.25 μg/0.5μL SCH23390; N = 8) into the BLA does not impair discriminative reward seeking. Saline and antagonist
groups exhibited more % port to the reward cue in comparison to the other cues during DC1, DC2, DC3,
and DC4. The agonist group also showed more % port to the reward cue than the other cues during DC1
and DC2. This group also showed more % port to the reward cue than the fear + safety and safety cues,
but not the fear cue, during DC3 and DC4. (B-E, right panels) BLA infusion of D1 receptor agonist or
antagonist did not significantly impair reward discrimination ratio.

Figure 6. Port percentage after BLA infusion of dopamine D1 receptor agonist,
antagonist or saline.
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Note. Systemic D1 receptor agonist or antagonist administration impairs fear and safety discrimination.
Systemic D1 receptor agonist administration also impairs fear discrimination and reward discrimination.
BLA infusion of agonist but not antagonist impairs fear and safety discrimination. Reward
discrimination is not affected by either BLA treatment.

Figure 7. Summary of results from systemic administration or BLA infusion of D1
receptor agonist or antagonist.

